疏肝化痰消癖散与乳块消片治疗肝郁气滞型乳腺增生症的临床疗效比较

Comparison of clinical effects between Shugan Huatan Xiaopi powder and Rukuaixiao tablets in the treatment of stagnation of liver-qi type breast hyperplasia

目的比较疏肝化痰消癖散和乳块消片治疗肝郁气滞型乳腺增生症的临床效果,探讨以疏肝理气为本,辅助化痰消积法和活血化瘀法的利弊。方法 98例肝郁气滞型乳腺增生症的女性患者为研究对象,随机分为研究组和对照组,各49例。研究组服用疏肝化痰消癖散颗粒,对照组服用乳块消片。对比治疗效果。结果研究组总有效率为94%,对照组总有效率为92%,两组差异无统计学意义(P>0.05)。结论两种药物在治疗肝郁气滞型乳腺增生症方面的能力基本持平,不存在显著差异,患者的治疗效果都非常突出,所以这两种制剂都值得在临床中推广应用,医护人员根据患者择优选择制剂类型。

Objective To compare clinical effects between Shugan Huatan Xiaopi powder and Rukuaixiao tablets in the treatment of stagnation of liver-qi type breast hyperplasia, to investigate advantages and disadvantages of methods by tretching liver to smooth qi, along with regulating qi and removing qi stagnation. Methods A total of 98 female patients with stagnation of liver-qi type breast hyperplasia as study subjects were randomly divided into research group and control group, with 49 cases in each group. The research group received Shugan Huatan Xiaopi powder, and the control group received Rukuaixiao tablets. Curative effects were compared. Results Total effective rate was 94% in the research group and 92% in the control group. There was no statistically significant difference between the two groups（P〈0.05）. Conclusion These two drugs provide similar effects in treating stagnation of liver-qi type breast hyperplasia, without significant difference. They have remarkably curative effect for patients, thus they can be promoted and applied in clinical usage. Medical staff can chose preferred drugs by patients＇ condtion.